Delivery Order SPE2DR25D3017-SPE2DR26F3EG1
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Progesterone 200 mg capsules (30-count units) under a firm fixed-price contract with a ceiling value of $7,344.92. The order was competitively awarded without set-aside designation and is scheduled for completion by September 26, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in that same city. This delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $15,661.45 to AmerisourceBergen Drug Corp for the supply of Progesterone 200 mg capsules (100-count units) under a firm fixed-price contract type. The award, issued on September 25, 2025, with an ultimate completion date of September 26, 2025, represents a competitive, non-set-aside procurement. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Progesterone 200 mg capsules (100-count units) on October 21, 2025, with an ultimate completion date of October 22, 2025. This competitively awarded, firm fixed-price delivery order has a ceiling value of $5,700.75 and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation and represents a child order under the company's...
- The Defense Logistics Agency awarded a delivery order valued at $2,208.42 to AmerisourceBergen Drug Corp for the supply of Progesterone 200 mg capsules (30-count units). The contract, awarded on October 31, 2025, is a firm fixed-price delivery order with an ultimate completion date of November 3, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This award carries no set-aside designation, indicating it was competitively awarded through open...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Progesterone 200 mg capsules (100 count) on June 3, 2025, with a ceiling value of $1,441.65 and an ultimate completion date of June 4, 2025. This competitively awarded, non-set-aside contract reflects a firm fixed-price delivery order executed under AmerisourceBergen's existing pharmaceutical supply framework with the federal government. The pharmaceutical product will be performed at the vendor's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Progesterone 200 mg capsules (100-count units) with a ceiling value of $3,930.74. Issued on October 23, 2025, with an ultimate completion date of October 24, 2025, this firm fixed-price contract represents a competitive award with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, the company's headquarters....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Progesterone 200 mg capsules (100-count units) with a ceiling value of $4,392.89. This is a firm fixed-price delivery order with an ultimate completion date of October 24, 2025, and represents a non-competitive set-aside contract. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $28.5 million to AmerisourceBergen Drug Corp for the supply of Progesterone 200 mg capsules (100-count units) on December 8, 2025, with an ultimate completion date of December 9, 2025. This firm fixed-price delivery order represents a non-competitive award under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which carries a total ceiling value of $1 billion...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Progesterone 200 mg capsules (100-count units) on July 14, 2025, with a ceiling value of $10,421.34 and a firm fixed price structure. This non-set-aside, competitively awarded contract is scheduled for ultimate completion by July 15, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a continuation of the company's critical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Progesterone 200 mg capsules (100-count units) valued at $3,229.04. This firm fixed-price delivery order, which represents a child contract under AmerisourceBergen's larger pharmaceutical supply agreement with DLA, will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania, with completion expected by November 18, 2025. The award utilized competitive...
- SPE2DR25D3017Indefinite Delivery Contract
- SPE2DR25D3017-SPE2DR26F3EG1Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Progesterone 200 mg capsules (100-count units) under a firm fixed-price contract valued at $27,383.21, with an ultimate completion date of December 4, 2025. The contract was competitively awarded with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same city. This delivery order represents one of numerous pharmaceutical supply transactions the company fulfills through its federal contract portfolio. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. This prime contract vehicle serves as a comprehensive global pharmaceutical support mechanism enabling AmerisourceBergen to supply a broad range of pharmaceutical products, generic and brand-name medications, vaccines, and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. The company's position as a major pharmaceutical distributor and critical federal medical procurement vendor is reflected in its consistent award of competitively bid, firm fixed-price delivery orders across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $27.4k | 12/2/25 |